An oncology centre will implement EU-funded software for pathology and a molecular lab, signalling a broader shift to integrated, interoperable diagnostics in public hospitals.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.
An EU-funded procurement will deliver and implement IT/software across the Pathomorphology Departments and the Central Molecular Laboratory of the Lower Silesian Oncology Center. The programme covers installation, staff training and maintenance, and is a clear marker of how diagnostics in public hospitals is becoming software-driven.
Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii has issued a notice for the delivery and implementation of IT/system software for pathology and molecular diagnostics. Published in October 2025, the specification is concise but sets out a full lifecycle approach.
The buyer states the project is financed with EU resources. The notice does not detail specific modules, integration standards or contract value, so questions about interoperability, analytics capability and links to existing hospital systems remain open at this stage.
European funds are increasingly underwriting hospital digitisation projects, from infrastructure to clinical software. In August 2022, the Centrum Pulmonologii i Torakochirurgii in Bystra sought servers, storage and licences as part of an EU-co-financed project to implement an integrated medical IT system and expand access to e-health services (link).
More recently, in October 2025, a Katowice oncology provider launched a procurement for software to manage its Pathomorphology Department, also funded by European resources and bundled with delivery, installation, training and a warranty (link). The pattern is consistent: European co-financing is enabling hospitals to move from standalone lab tools to connected clinical systems with clear implementation and support provisions.
Across Poland, hospitals are buying software and equipment that tighten the links between laboratory workflows and clinical care, with interoperability a recurrent theme.
In September 2022, Samodzielny Publiczny Zakład Opieki Zdrowotnej MSWiA with the Warmian-Masurian Oncology Centre in Olsztyn advertised an electronic system to support chemotherapy treatment for cytostatics laboratories. The system was to operate as part of the HIS, integrate using the HL7 standard, and enable two-way data exchange with full documentation of medicine distribution to the patient (link). That emphasis on standards-based integration is a useful marker for what buyers expect from vendors.
Pathology services are also expanding their digital footprint. In December 2023, the University Clinical Hospital in Rzeszów sought pathomorphology software alongside thermal transfer printers for microscope slides, backing up digital workflows with reliable specimen labelling (link).
Automation is moving beyond discrete instruments. In March 2025, Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie launched a project to acquire software that automates technological processes in the Department of Pathomorphology and the Mortuary, with a requirement for a complete software and compatible hardware solution (link).
The move towards digital pathology is visible in equipment buys too. In October 2025, the public hospital in Białystok ordered a scanner for histological specimens together with software for digital pathology, alongside other lab devices (link). And in May 2025, the Multispecialty Hospital in Nowa Sól sought a specimen scanner with AI software for its Pathomorphology Unit, suggesting interest in algorithmic support for image review (link).
Integration across departments is another thread. In February 2025, the Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej in Staszów set out to connect its Laboratory Information System with the HIS and to link teleradiology with the HIS, a reminder that pathology, imaging and clinical systems are being knitted together to streamline care pathways (link).
Taken together, these projects show a consistent direction of travel: hospitals want interoperable lab systems, automation that reduces manual steps, and implementations that include training and long-term support. The Lower Silesian procurement aligns with that trajectory, with a particular focus on bringing pathology and molecular diagnostics onto a common, supported IT footing.
Key questions now are about scope and integration. The notice does not specify functional modules or data standards, so the technical approach will become clearer as procurement documents are published and evaluated. Given other hospitals’ emphasis on HL7-based exchange, automation and links to digital pathology equipment, it will be worth watching whether similar conditions appear here.
The inclusion of training and maintenance signals an implementation that must bring clinicians, laboratory scientists and IT together. How the centre sequences deployment across pathology and the central molecular laboratory, and how it supports users through the transition, will determine uptake.
Finally, EU funding is an important enabler. As more hospitals channel European resources into diagnostics IT, competition among suppliers with proven integration and support track records is likely to intensify. The outcome of this procurement will offer another data point on how public providers are shaping their digital pathology and molecular workflows.
Follow Tenderlake on LinkedIn for concise insights on public-sector tenders and emerging procurement signals.